Combination of | |
---|---|
Chlorproguanil | Antimalarial drug |
Dapsone | Antibiotic |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
Chlorproguanil/dapsone (sold commercially as Lapdap) was a fixed dose antimalarial combination containing chlorproguanil and dapsone, [1] which act synergistically against malaria. The drug was withdrawn in 2008 following increasing evidence of toxicity in the form of haemolysis occurring in patients with G6PD deficiency. [2]
Combination of | |
---|---|
Chlorproguanil | Antimalarial drug |
Dapsone | Antibiotic |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
Chlorproguanil/dapsone (sold commercially as Lapdap) was a fixed dose antimalarial combination containing chlorproguanil and dapsone, [1] which act synergistically against malaria. The drug was withdrawn in 2008 following increasing evidence of toxicity in the form of haemolysis occurring in patients with G6PD deficiency. [2]